Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227441 · ClinicalTrials.gov registry record
Chronic Infections and Inflammation in ME/CFS: An Observational Study
A clinical trial of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07227441: Recruiting study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, sponsored by University of California, San Francisco.
NCT07227441 is a study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07227441, a study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
CHIIME is a study of people who have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). People who do not have this condition will also be enrolled. Volunteers will be observed and sampled over time to identify the long-terms biological drivers and impact of their condition. The overall goal is to understand the biological and physiological mechanisms that are driving this condition.
Primary Outcome
The proportion of men and women participating in the baseline visit.
Conditions Studied
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2030-09 |
What NCT07227441 shows while recruiting
NCT07227441 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome appearing as the primary indexed condition, and to 0 interventions.
NCT07227441 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07227441 about?
NCT07227441 is a clinical study titled "Chronic Infections and Inflammation in ME/CFS: An Observational Study". CHIIME is a study of people who have myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). People who do not have this condition will also be enrolled. Volunteers will be observed and sampled over time to identify the long-terms biological drivers and impact of their condition. The overall go...
What is the current status of trial NCT07227441?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2026-01-01. Estimated completion is 2030-09.
What conditions does trial NCT07227441 study?
This clinical trial studies the following conditions: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Who is sponsoring clinical trial NCT07227441?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227441 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI